Joel Greenblatt Bets on eBay, Intel, Biogen

The investor's top buys in the 1st quarter

Author's Avatar
Jun 03, 2016
Article's Main Image

Joel Greenblatt (Trades, Portfolio) is founder and managing partner of Gotham Asset Management LLC. He is known for the invention of Magic Formula Investing and founded the New York Securities Auction Corporation (NYSAC).

The guru bought 859,283 shares in United Technologies Corp. (UTX) with an impact of 0.96% on the portfolio.

The company provides high technology products and services to building systems and the aerospace industry. Its business segments are Otis, UTC Climate, Controls & Security, Pratt & Whitney, UTC Aerospace Systems and Sikorsky.

During the last quarter adjusted EPS grew 2% from the first quarter of 2015, and sales had 2% growth.

GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 26.65% and ROA of 8.24% that are outperforming 85% of the companies in the Global Aerospace & Defense industry. Financial strength has a rating of 7 out of 10 with cash to debt of 0.31 that is below the industry median of 0.44.

Barrow, Hanley, Mewhinney & Strauss is the company's largest shareholder among the gurus with 1.84% of outstanding shares followed by Chris Davis (Trades, Portfolio) with 1.06%, Ken Fisher (Trades, Portfolio) with 1%, Mason Hawkins (Trades, Portfolio) with 0.85% and First Pacific Advisors (Trades, Portfolio) with 0.76%.

The investor acquired 1,695,068 shares in Baxter International Inc. (BAX) with an impact of 0.78% on the portfolio.

The company develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic conditions.

During the fourth quarter worldwide sales totaled $2.6 billion, an increase of 2% on a constant currency basis as compared to the prior-year period and also exceeded the company’s previously issued guidance.

GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 47.86% and ROA of 717.28% that are outperforming 94% of the companies in the Global Medical Instruments & Supplies industry. Financial strength has a rating of 8 out of 10 with cash to debt of 1.03 that is below the industry median of 1.81.

The largest shareholder among the gurus is Daniel Loeb (Trades, Portfolio) with 9.75% of outstanding shares followed by Vanguard Health Care Fund (Trades, Portfolio) with 2.02%, Richard Pzena (Trades, Portfolio) with 0.74%, Tweedy Browne (Trades, Portfolio) with 0.45%, Mairs and Power (Trades, Portfolio) with 0.37%, David Einhorn (Trades, Portfolio) with 0.22% and Tweedy Browne (Trades, Portfolio) Global Value with 0.2%.

The guru increased his shares in eBay Inc. (EBAY) by 1,913.77% with an impact of 0.72% on the portfolio.

The company is a commerce platform and provides an online marketplace for sale of goods. Its business segments are Marketplaces, Payments and Enterprise.

During the first quarter gross merchandise volume (GMV) increased 5% on a foreign exchange (FX) neutral basis and 1% on an as-reported basis, and revenues grew 6%.

GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 13.46% and ROA of 5.41% that are outperforming 66% of the companies in the Global Specialty Retail industry. Financial strength has a rating of 7 out of 10 with cash to debt of 0.89 that is below the industry median of 1.00.

PRIMECAP Management (Trades, Portfolio) is the company's largest shareholder among the gurus with 0.72% of outstanding shares followed by Pioneer Investments (Trades, Portfolio) with 0.49%, George Soros (Trades, Portfolio) with 0.32%, Greenblatt with 0.25% and Jim Simons (Trades, Portfolio) with 0.25%.

The guru increased his shares in Intel Corp. (INTC) by 280.95% with an impact of 0.63% on the portfolio.

The company develops integrated digital technology products like integrated circuits for industries such as computing and communications.

GuruFocus gives the stock a profitability and growth rating of 8 out of 10 with ROE of 19.65% and ROA of 11.78% that are outperforming 89% of the companies in the Global Semiconductors industry. Financial strength has a rating of 9 out of 10 with cash to debt of 0.60 that is below the industry median of 2.07.

The largest shareholder among the gurus is PRIMECAP Management (Trades, Portfolio) with 0.67% of outstanding shares followed by Fisher with 0.42%, Barrow, Hanley, Mewhinney & Strauss with 0.41%, First Eagle Investment (Trades, Portfolio) with 0.33%, Bill Nygren (Trades, Portfolio) with 0.25%, Pzena with 0.2% and Greenblatt with 0.05%.

The investor increased his shares in Biogen Inc. (BIIB) by 253.14% with an impact of 0.62% on the portfolio.

The company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.

First-quarter revenue grew 7% versus the same period in the prior year, driven by a 15% increase in worldwide TECFIDERA® revenues. Non-GAAP diluted earnings per share (EPS) increased 25% and non-GAAP net income attributable to Biogen increased 17%.

GuruFocus gives the stock a profitability and growth rating of 9 out of 10 with ROE of 33.90% and ROA of 19.89% that are outperforming 94% of the companies in the Global Biotechnology industry. Financial strength has a rating of 9 out of 10 with cash to debt of 0.55 that is below the industry median of 56.57.

PRIMECAP Management (Trades, Portfolio) is the company's largest shareholder among the gurus with 7.42% of outstanding shares followed by Vanguard Health Care Fund (Trades, Portfolio) with 1.74%, Frank Sands (Trades, Portfolio) with 1.43%, Spiros Segalas (Trades, Portfolio) with 0.58% and Andreas Halvorsen (Trades, Portfolio) with 0.11%.

The investor increased his shares in Express Scripts Holding Co. (ESRX) by 224.25% with an impact of 0.62% on the portfolio.

The company offers health care management and administration services such as managed care organizations, health insurers, workers' compensation plans and government health programs.

During the first quarter GAAP net income grew 19% and GAAP diluted earnings per share increased 35%. Net cash flow provided by operating activities had a growth of 167%.

GuruFocus gives the stock a profitability and growth rating of 8 out of 10 with ROE of 15.04% and ROA of 4.92% that are outperforming 73% of the companies in the Global Health Care Plans industry. Financial strength has a rating of 7 out of 10 with cash to debt of 0.11 that is below the industry median of 1.63.

The largest shareholder among the gurus is Dodge & Cox with 3.49% of outstanding shares followed by Barrow, Hanley, Mewhinney & Strauss with 1.54%, Davis with 0.81%, David Rolfe (Trades, Portfolio) with 0.63%, Manning & Napier Advisors Inc. with 0.58%, Charles Brandes (Trades, Portfolio) with 0.34% and Jeremy Grantham (Trades, Portfolio) with 0.26%.

The guru increased his shares in McKesson Corp. (MCK) by 682.77% with an impact of 0.57% on the portfolio.

The company distributes pharmaceuticals, medical supplies and health care information technology that make health care safer while reducing costs.

Fourth-quarter revenues grew 7% year over year, and GAAP earnings per diluted share from continuing operations increased 31% from the same quarter of a year before.

GuruFocus gives the stock a profitability and growth rating of 6 out of 10 with ROE of 25.99% and ROA of 4.07% that are outperforming 52% of the companies in the Global Medical Distribution industry. Financial strength has a rating of 8 out of 10 with cash to debt of 0.50 that is below the industry median of 0.69.

Vanguard Health Care Fund (Trades, Portfolio) is the company's largest shareholder among the gurus with 3.18% of outstanding shares followed by Larry Robbins (Trades, Portfolio) with 0.41%, Greenblatt with 0.16%, First Pacific Advisors (Trades, Portfolio) with 0.04% and Jerome Dodson (Trades, Portfolio) with 0.04%.

The guru bought 507,211 shares in The Hershey Co. (HSY) with an impact of 0.52% on the portfolio.

The company is engaged in the manufacturing, marketing, selling and distribution of chocolate and sugar confectionery products, pantry items, such as baking ingredients, toppings and beverages, and gum and mint refreshment products.

GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 48.50% and ROA of 9.06% that are outperforming 80% of the companies in the Global Confectioners industry. Financial strength has a rating of 6 out of 10 with cash to debt of 0.11 that is below the industry median of 0.68.

The largest shareholder among the gurus is Pioneer Investments (Trades, Portfolio) with 1.75% of outstanding shares followed by Simons with 1.17%, Greenblatt with 0.24%, Manning & Napier Advisors Inc. with 0.05%, Ray Dalio (Trades, Portfolio) with 0.03%, Mairs and Power (Trades, Portfolio) with 0.03% and Tom Gayner (Trades, Portfolio) with 0.01%.

Start a free seven-day trial of Premium Membership to GuruFocus.